Skip to content
← Back to this collection

PUBLICATIONS · 34516954

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Oct
First author
Schuster SJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Nov;18(11):676. doi: 10.1038/s41571-021-00567-0.
    note
    Source null
    related pmid
    34580475
    relationship
    Comment in

Authors and identifiers

  1. name
    Schuster SJ
    type
    Author
  2. name
    Tam CS
    type
    Author
  3. name
    Borchmann P
    type
    Author
  4. name
    Worel N
    type
    Author
  5. name
    McGuirk JP
    type
    Author
  6. name
    Holte H
    type
    Author
  7. name
    Waller EK
    type
    Author
  8. name
    Jaglowski S
    type
    Author
  9. name
    Bishop MR
    type
    Author
  10. name
    Damon LE
    type
    Author
  11. name
    Foley SR
    type
    Author
  12. name
    Westin JR
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Schuster SJ
    type
    Author
  2. name
    Tam CS
    type
    Author
  3. name
    Borchmann P
    type
    Author
  4. name
    Worel N
    type
    Author
  5. name
    McGuirk JP
    type
    Author
  6. name
    Holte H
    type
    Author
  7. name
    Waller EK
    type
    Author
  8. name
    Jaglowski S
    type
    Author
  9. name
    Bishop MR
    type
    Author
  10. name
    Damon LE
    type
    Author
  11. name
    Foley SR
    type
    Author
  12. name
    Westin JR
    type
    Author
bibliography ids
  1. nci-bib-2c0b6dee4d18d4026858ac79
book metadata
content sha256
2e17d7d6ab035211f76ff123e7778dad74a3eb7a121f23c1abe8e64d7b24d933
document type
citation
dois
  1. 10.1016/S1470-2045(21)00375-2
electronic publication date
display
2021 Sep 10
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34516954
immutable id
pubmed:34516954@2e17d7d6ab035211f76ff123e7778dad74a3eb7a121f23c1abe8e64d7b24d933
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
10
name
The Lancet. Oncology
nlm unique id
100957246
pages
1403-1415
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Nov;18(11):676. doi: 10.1038/s41571-021-00567-0.
    note
    Source null
    related pmid
    34580475
    relationship
    Comment in
outcomes validated
false
pmid
34516954
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
de3816966a89410d5d4ad36d1ca0cd919c8b2e89a35b58cc077654e16688864d
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Oct
precision
month
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34516954/
title
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.

Preserved source evidence · Independent clinical review pending · Not medical advice